NASDAQ

Спайдер повышается перед открытием торгов на NYSE.  

• Европейские индексы на положительной территории.  

SPY (внутридневной график)  рост движение на   премаркете. Сопротивление: 174.00            Поддержка: 173.00                  
Премаркет NYSE/NASDAQ:
Gapping up:

• In reaction to strong earnings/guidance: RAD +13.2%.
• M&A news: MCBI +24.4% (co and East West Bancorp (EWBC) enter into definitive agreement for merger), BMRN +8.9% (Bloomberg discusses speculation that Roche (RHHBY) may secure financing for BMRN bid, according to reports).
• Select shipping related names showing strength: DRYS +6.7%, DSX +4.4%, GNK +3.5%, BALT +3.3%, FRO +1.5%.
• Other news: ACUR +12.6% (provided update on NEXAFED launch: now being sold in over 2,600 pharmacies nationwide), A +11.3% (to separate into two public companies; spinoff is not anticipated to impact co's guidance for fiscal year 2013), ONVO +10.4% ( diclosed it entered into an agreement with Hoffmann La Roche exploring the use of 3D liver tissue in toxicology), TSPT +10% (Retrophin proposed acquisition of co for $4 per share), KNDI +7.5% (confirms Chinese Government issued 2013-2015 subsidy policy for new energy vehicles), TTWO +4.7% (Grand Theft Auto V sales may have hit ~ $1 bln worldwide during first day of launch, according to reports), ISIS +3.7% (reports follow-up data from iSIS-SMN Rx Phase 1 study in children with spinal muscular atrophy), HIMX +2.8% (cont strength), TTM +2.6% (strong move in the Sensex overnight), IBN +1.9% (stong Sensex mkt overnight), MT +1.8% (ArcelorMittal and Technip (TKPPY) signed contract for the supply of high-performance steel wires), ICUI +1.8% (reports two new clinical studies show ChemoClave System improves safety), AAPL +1.1% (WantChinaTimes discusses declining market share for AAPL in China).

( Читать дальше )

Спайдер незначительно повышается перед открытием торгов на NYSE.  

• Европейские индексы на положительной территории.  

SPY (внутридневной график)  боковое движение на   премаркете. Сопротивление: 171.00            Поддержка: 171.50                 
Премаркет NYSE/NASDAQ:
Gapping up:

• In reaction to strong earnings/guidance: AFOP +13.4%, ADBE +5.7%, FDX +2.8%, GIS +0.6%.
• M&A news: GRPN +0.8% (cquires local experience startup SideTour).
• Select EU financial related names showing strength: IRE +1.9%, SAN +1.9%, HBC +1.4%, BCS +1.2%.
• Other news: CIS +0% (enters into a merger agreement for a 'going private' transaction;), INVN +4.9% (still checking), DLTR +3.5% (announced $2 bln share repurchase authorization) CPRX +2.4% (still checking), WDAY +1.2% (Salesforce.com (CRM) announced plans to integrate the entire Salesforce and Workday product lines), AAPL +1.1% (releasing iOS 7 today, also Pacific Crest's increases estimates), BMRN +1% (possitive mention on Mad Money), CRZO +1% (possitive mention on Mad Money).

( Читать дальше )

Спайдер незначительно повышается перед открытием торгов на NYSE.  

• Европейские индексы на отрицательной территории.  

SPY (внутридневной график)  рост   на   премаркете. Сопротивление: 170.50            Поддержка: 170.00                 
Премаркет NYSE/NASDAQ:
Gapping up:

• In reaction to strong earnings/guidance: SUTR +22.8%.
• M&A news: HUN +8.4% (confirms agreement to acquire ROC's Performance Additives and Titanium Dioxide businesses).
• Select metals/mining stocks trading higher: HMY +2.8%, GFI +1.9%, ABX +1.5%, HL +1.3%, AG +1.3%, GG +1%, GDX +1%.
• Other news: RPRX +31.1% (reports preliminary findings: Second Pivotal study and 6-month safety study support Androxal approvability), KYTH +30.5% (announced positive ATX-101 top line Phase 3 trial results for the reduction of submental fat), AGEN +23.7% ('positive' follow-on Phase 2 Results for Brain cancer vaccine in newly diagnosed patients;), ARO +12.1% (Hummingbird disclosed a 7.96% active stake in a 13D filing ), DFS +4.9% (reports August card metrics), BCRX +2.8% (awarded contract by the National Institute of Allergy and Infectious Diseases to develop BCX4430 for the treatment of Marburg virus disease), TPLM +2.2% (expands Caliber Infrastructure System), BSX +2.2% (reports favorable six-month results from Lotus Valve System clinical trial), RMTI +1.9% (FDA acceptance of Triferic as proprietary trade name for investigational iron-delivery drug SFP), PERI +1.7% (bounce following yest weakness), TTWO +1.6% (GTA release today), SNY +1.4% (Genzyme receives European Commission approval for multiple sclerosis treatment Lemtrada).

( Читать дальше )

Добрый вечер, выкладываю сделки. Делал скрины и старался в каждом подчеркнуть индивидуальность акции. 
Что бы вам было легче ориентироваться :
Верхний график — 1 min 
Левый нижний график — SPY 1 min
Правый нижний график — 1 day ( за 6 месяцев ) .
Шкала в минутных графиках 0.50 $ — восновном хорошие уровни ну и заходы происходят на таких числах 15.00, 15.50, 16.00, 17.00, 18.50 и тд.Шкала в day графике через каждые 5 $ — на дневке сильные уровнями и тд являются числа кратные 5 .
Вопрос: Как ты держишь позицию ?
Если позиция 100 % то
20 % позиции — выхожу эмоционально — для преодоления эмоций и отбития стопа.Остальную позицию закрываю по тех анализу и тд. 
P.s сори за ошибки, не успел проверить .







( Читать дальше )

Спайдер повышается перед открытием торгов на NYSE.  

• Европейские индексы на положительной территории.  

SPY (внутридневной график)  рост   на   премаркете. Сопротивление: 171.50            Поддержка: 171.00                 
Премаркет NYSE/NASDAQ:
Gapping up:

• M&A news: BZ +26.7% (to be acquired by Packaging Corp. of America (PKG) for $12.55 per share in cash), PKG +10.9% (acquisition is expected to be accretive to earnings immediately), SOHU +7.1% (Sohu.com, Sogou and Tencent (TCEHY) jointly announce strategic cooperation).
• Select Potash related names showing strength; move attributed to speculation that Belarus issues will be resolved: CF +2%, POT +1.9%, MOS +1.7%.
• Select metals/mining stocks trading higher: CLF +2.9%, MT +2.7%, X +1.7%, BHP +1.7%, RIO +1.5%.
• Select solar related names showing strength ahead of this weekend's summit in China: YGE 4%, STP 3.8%, JKS 1.9%, SPWR 1.1%.

( Читать дальше )

Гигант розничной торговли Wal-Mart  (NYSE: WMT) продолжает сохранять свою рентабельность  за счет открытия новых магазинов и расширяет свое влияние за пределами США. Однако, сохраняет ли компания свой рост только за счет новых магазинов? Какова отдача от магазинов компании в сравнении с конкурентами?
Рентабельность магазинов
Для лучшего понимания источников прибыли Wal-Mart мы разделили их на 3 основных сегмента: Wal-Mart U.S, Wal-Mart international и Sam's Club. Для начала проанализируем  изменение количества магазинов в каждом бизнес –сегменте.

Как видно из таблицы, international сегмент вырос самыми быстрыми темпами в прошлом квартале – 7,2% рост в годовом исчислении.  А вот магазины Sam's Club, наоборот, росли медленно – 1,3%.
Теперь посмотрим на изменение продаж и операционной прибыли в каждом сегменте.



( Читать дальше )

Добрый вечер, выкладываю сделки. Делал скрины и старался в каждом подчеркнуть индивидуальность акции.
Что бы вам было легче ориентироваться :
Верхний график — 1 min
Левый нижний график — SPY 1 min
Правый нижний график — 1 day ( за 6 месяцев ) .
Шкала в минутных графиках 0.50 $ — восновном хорошие уровни ну и заходы происходят на таких числах 15.00, 15.50, 16.00, 17.00, 18.50 и тд.Шкала в day графике через каждые 5 $ — на дневке сильные уровнями и тд являются числа кратные 5 .
Вопрос: Как ты держишь позицию ?
Если позиция 100 % то
20 % позиции — выхожу эмоционально — для преодоления эмоций и отбития стопа.Остальную позицию закрываю по тех анализу и тд.
P.s сори за ошибки, не успел проверить .




( Читать дальше )

Спайдер остается без изменений перед открытием торгов на NYSE.  

• Европейские индексы на отрицательной территории.  

SPY (внутридневной график)  боковое движение   на   премаркете. Сопротивление: 169.75           Поддержка: 168.75                
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: ULTA +14.3%, LFVN +5.9%, UNFI +4.2%, ALOG +3.2%, MBII +1.8%.
Other news: SGMO +4.6% (announced presentation of clinical data demonstrating functional control of viremia in HIV-infected subjects treated SB-728-T), SFNC +2.9% (to acquire Metropolitan National Bank), CTIC +2.8% (announces sales of Conv Pref Stock), LDK +2.6% (engages financial advisor for offshore debt obligations), SUNE +1.1% (public offering of 30 mln shares of common stock at a price of $7.25/share), EVTC +0.7% (prices 20 mln shares of common stock by affiliate of Apollo Global Mgmt and other selling shareholders at $22.50 per share ).
Analyst comments: OCLR +6.2% (upgraded to Buy from Neutral at B. Riley & Co), SWY +3.2% (upgraded to Outperform from Neutral at Credit Suisse), SFNC +2.9% (pgraded to Outperform from Mkt Perform at Raymond James, upgraded to Overweight from Equal-Weight at a boutique firm), WFT +2% (upgraded to Outperform from Neutral at Credit Suisse), INTC +1.9% (upgraded to Buy from Hold at Jefferies), LULU +1.4% (upgraded to Outperform from Neutral at Credit Suisse), AET +1.2% (pgraded to Buy from Neutral at BofA/Merrill), CMC +1.1% (upgraded to Neutral from Underperform at BofA/Merrill)


( Читать дальше )

Спайдер повышается перед открытием торгов на NYSE.  

• Европейские индексы на положительной территории.  

SPY (внутридневной график)  рост   на   премаркете. Сопротивление: 169.50           Поддержка: 169.00               
Премаркет NYSE/NASDAQ:
Gapping up:

• In reaction to strong earnings/guidance: NTWK +15.7%.
• M&A news: OCLR +48.1% (II-VI announces acquisition of co's Switzerland-Based Semiconductor laser business for $115 mln; expands credit facility), STSA +9.2% (to merge with Umpqua (UMPQ); Sterling shareholders to receive 1.671 shs of UMPQ and $2.18 in cash).
• Other news: P +5.2% (named Brian McAndrews Chief Executive Officer, President and Chairman) SSH +4.5% (implants first patient in C-Pulse Counter HF US Pivotal Trial), SNTA +4.5% ( announces Fast Track designation granted for ganetespib in non-small cell lung adenocarcinoma), RCL +3.7% (increases quarterly dividend to $0.25 per common share, previous $0.12 per common share), SOL +3.5% (still checking), CMO +3% (to be added to the S&P SmallCap 600), VRTX +2.4% (to be added to the S&P 500),  HK +2.4% (enters into agreements to divest non-core conventional assets for ~ $302 mln), NBS +1.9% (awarded $147,765 NIH grant for treatment of skin wounds in Scleroderma patients), AVAV +1.2% (Engaged Capital sent additional letter to AVAV's Board; Engaged has withdrawn its director nomination of one candidate from this year's election), FIO +1.2% (Bloomberg last night discussed takeover speculation in FIO (speculation has been ongoing this week)), AME +1.1% (to be added to the S&P 500), QCOM +1% (announced new $5 bln stock repurchase program) YHOO +1.0% (CEO says active users have grown by 20% since she took over as CEO, according to reports), AAPL +1% (Carl Ichan stated he added to position on CNBC interview; Digitimes discusses that total tablet shipments will top PC shipment by Q4 of 2014, according to reports).

( Читать дальше )

Аналитика NYSE на 11 сентября
 
Спайдер остается без изменений перед открытием торгов на NYSE.  

• Европейские индексы на положительной территории.

 
SPY (внутридневной график)  боковое  движение   на   премаркете. Сопротивление: 169.00           Поддержка: 168.50
 
Премаркет NYSE/NASDAQ:
Gapping up:

• In reaction to strong earnings/guidance: LCI +4.1%, UNIS +1.6%.
• Other news: HNR +37.3% (announces exclusive negotiations to sell co including Venezuela; spin-off of remaining assets for total consideration of ~ $373 mln), VTUS +10.5% (announces positive results from clinical dermal safety and pharmacokinetic studies of Diltiazem), SNX +8.9% (Synnex and IBM announces strategic partnership in customer care market; SYNNEX will acquire IBM's worldwide customer care business process outsourcing services business for $505 mln), PSTI +5.9% (Pluristem Therapeutics receives US patent for treatment of peripheral artery disease), SHLD +4.4% ( NYPost discusses recent strength in shares of SHLD on speculation of undervalued real estate assets), THRX +3.6% (confirms FDA Advisory Committee recommends approval of umeclidinium/vilanterol for the treatment of COPD), BID +3% (announces review of capital allocation and financial policies), XOOM +2.3% (prices 4,403,270 shares of common stock in follow on offering at $30.50 per share, shares sold by co and selling share holders), KIOR +2.1% (cont strength following yesterday's gains), YGE +1.9% (to supply 28 mw of pv modules for the state grid corporation of China), NWSA +1.2% (Southeastern Asset Management disclosed 11.9% passive stake in 13G filing out last night after the close), RCL +0.9% (easing Syria/Med Sea tensions).

( Читать дальше )